双硫死亡与其他细胞死亡在卵巢癌治疗中的研究进展  

Research progress on disulfideptosis and other cell death pathways in ovarian cancer treatment

作　　者：杨佳林 谢晓英 YANG Jialin;XIE Xiaoying(The First Clinical College of Gannan Medical University,Ganzhou 341000,China;Department of Obstetrics and Gynecology,the First Affiliated Hospital of Gannan Medical University,Ganzhou 341000,China)

机构地区：[1]赣南医科大学第一临床医学院,江西赣州341000 [2]赣南医科大学第一附属医院妇产科,江西赣州341000

出　　处：《广州医药》2025年第4期452-456,共5页Guangzhou Medical Journal

摘　　要：卵巢癌是导致女性死亡的全球第五大原因,其治疗效果受限于早期诊断和治疗方案的有限性。近年来,随着靶向治疗的不断发展,细胞死亡途径作为治疗靶点受到广泛关注,其中双硫死亡作为一种新发现的程序性细胞死亡形式,为癌症治疗提供了新的思路。文章探讨了双硫死亡及其他主要细胞死亡途径包括自噬、细胞焦亡、坏死性凋亡、铁死亡和铜死亡在卵巢癌治疗中的研究进展,有望为卵巢癌患者提供更有效的治疗选择。Ovarian cancer ranks as the fifth deadliest cancer among women worldwide,with treatment efficacy hampered by limited early diagnosis and therapeutic options.In recent years,with the continuous development of targeted therapies,cell death pathways have gained widespread attention as therapeutic targets.Among them,disulfideptosis,a newly discovered form of programmed cell death,offers a novel avenue for cancer treatment.This review aims to explore the research progress of disulfideptosis and other major cell death pathways including autophagy,apoptosis,necroptosis,ferroptosis,and cuproptosis in ovarian cancer therapy,with the potential to provide more effective treatment options for ovarian cancer patients.

关 键 词：卵巢癌 双硫死亡 细胞死亡 癌症治疗 

分 类 号：R737.31[医药卫生—肿瘤]